When It's Too Trying for Trials: A Commentary on a Different Approach for Testing a Probiotic, Saccharomyces boulardii, to Prevent Healthcare-associated Clostridioides difficile Infections

Clin Infect Dis. 2021 Nov 2;73(9):e2519-e2520. doi: 10.1093/cid/ciaa798.

Author

Lynne V McFarland¹

Affiliation

¹ Dept of Medicinal Chemistry, University of Washington, Seattle, Washington, USA.

PMID: 32566936
DOI: 10.1093/cid/ciaa798

No abstract available

Keywords: Clostridioides difficile infections; Saccharomyces boulardii; colitis; infection control; nosocomial.

Publication types

Editorial
Comment

MeSH terms

Clostridioides
Clostridium Infections* / prevention & control
Delivery of Health Care
Humans
Probiotics*
Saccharomyces boulardii*